Lin28B overexpression is observed in hepatocellular cancer (HCC) [21], breast cancer [21], lung cancer [21], colon cancer [22], esophageal cancer [18], melanoma [21], gastric cancer [23] and oral squamous cell carcinoma (OSCC) [19]. Here, LIN28B is linked to oral cavity squamous cell carcinoma.